Bui Le Minh, Lee Ju Young, Geraldi Almando, Rahman Ziaur, Lee Jun Hyoung, Kim Sun Chang
Department of Biological Sciences, Korea Advanced Institute of Science and Technology, 291 Daehak-ro, Yuseong-gu, Daejeon 305-701, Republic of Korea.
Department of Biological Sciences, Korea Advanced Institute of Science and Technology, 291 Daehak-ro, Yuseong-gu, Daejeon 305-701, Republic of Korea.
J Biotechnol. 2015 Jun 20;204:33-44. doi: 10.1016/j.jbiotec.2015.03.025. Epub 2015 Apr 6.
As the increasing demand from both chemical and fuel markets, the interest in producing n-butanol using biological route has been rejuvenated to engineer an economical fermentation process, competing with the currently-dominant chemical synthesis. n-Butanol has been traditionally produced from the ABE fermentation of Clostridium acetobutylicum. This system, however, is not economically feasible due to its limited efficiency and the lack of genetic modification tools for further improvements. Alternatively, n-butanol synthesis pathway was successfully transferred into Escherichia coli and rapidly improved to reach a level of production comparable to the native producer. Nevertheless, the toxicity of n-butanol has become a common issue that either approach has to deal with. Previously, we reported our success in improving n-butanol tolerance in E. coli by engineering an Artificial Transcription Factor (ATF) that can modify the expression level of multiple targets simultaneously and improved the n-butanol tolerance of MG1655 strain to 1.5% (vol/vol) n-butanol. However, it was observed that some possible n-butanol tolerance mechanisms did not occurred upon the ATF expression, especially the membrane-related functions such as the homeoviscous adaptation, iron uptaking system, and efflux pump system. In this work, we attempted to enhance the n-butanol tolerance associated with the ATF by combining it with the membrane-related functions in E. coli, including the overexpression of fatty acid synthesis genes, iron-uptaking protein FeoA, and introducing a SrpABC efflux pump from Pseudomonas putida into E. coli. The synergistic effect of this combinatorial approach led to 4, 5, and 9-fold improved growths in the cultures containing 1, 1.5, and 2% (vol/vol) n-butanol, respectively, of an MG1655 knockout strain engineered for n-butanol production, and expanded the tolerance limit to 2% (vol/vol) n-butanol.
随着化学和燃料市场需求的不断增加,利用生物途径生产正丁醇的兴趣得以恢复,旨在设计一种经济的发酵工艺,与目前占主导地位的化学合成方法竞争。正丁醇传统上是通过丙酮丁醇梭菌的ABE发酵生产的。然而,由于其效率有限且缺乏进一步改进的基因编辑工具,该系统在经济上并不可行。作为替代方案,正丁醇合成途径已成功转移到大肠杆菌中,并迅速得到改进,使其产量达到与天然生产者相当的水平。尽管如此,正丁醇的毒性已成为这两种方法都必须应对的常见问题。此前,我们报道了通过构建一种人工转录因子(ATF)成功提高了大肠杆菌对正丁醇的耐受性,该转录因子可以同时调节多个靶点的表达水平,并将MG1655菌株对正丁醇的耐受性提高到1.5%(体积/体积)。然而,观察到在ATF表达后,一些可能的正丁醇耐受机制并未出现,特别是与膜相关的功能,如同型粘性适应、铁摄取系统和外排泵系统。在这项工作中,我们试图通过将其与大肠杆菌中与膜相关的功能相结合来增强与ATF相关的正丁醇耐受性,包括脂肪酸合成基因的过表达、铁摄取蛋白FeoA以及将恶臭假单胞菌的SrpABC外排泵引入大肠杆菌。这种组合方法的协同效应导致在含有1%、1.5%和2%(体积/体积)正丁醇的培养物中,为生产正丁醇而构建的MG1655基因敲除菌株的生长分别提高了4倍、5倍和9倍,并将耐受极限扩大到2%(体积/体积)正丁醇。